Canaccord Genuity reiterated coverage on Sesen Bio with a new price target
$SESN
Biotechnology: Pharmaceutical Preparations
Health Care
Canaccord Genuity reiterated coverage of Sesen Bio with a rating of Buy and set a new price target of $7.00 from $5.00 previously